Specialty Pharmaceutical Company with a Focus in Pain and Addiction

Filing date Description Form Filing Group Filer View

Statement of changes in beneficial ownership of securities

4
3,4,5
ODONNELL FRANCIS E JR 0000899243-18-024561.pdf 0000899243-18-024561.rtf View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
Davis Todd C 0000899243-18-023257.pdf 0000899243-18-023257.rtf View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
ODONNELL FRANCIS E JR 0000899243-18-022886.pdf 0000899243-18-022886.rtf View HTML

A statement of beneficial ownership of common stock by certain persons

SC 13G
3,4,5
0000919574-18-005712.pdf 0000919574-18-005712.rtf 0000919574-18-005712.xls View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
Greenleaf Peter 0000899243-18-022577.pdf 0000899243-18-022577.rtf View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
Watson W. Mark 0000899243-18-022575.pdf 0000899243-18-022575.rtf View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
Broadfin Capita 0000899243-18-022576.pdf 0000899243-18-022576.rtf View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
Davis Todd C 0000899243-18-022574.pdf 0000899243-18-022574.rtf View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
Plesha Scott M. 0000899243-18-022309.pdf 0000899243-18-022309.rtf View HTML

Report of unscheduled material events or corporate event

8-K
Current Reports
0001193125-18-244338.pdf 0001193125-18-244338.rtf 0001193125-18-244338.xls View HTML

Copyright Morningstar